RecruitingNCT05963061

Chronic Myeloid Leukemia (CML) Real-Life Database

Sponsor

University Hospital, Clermont-Ferrand

Enrollment

3,500 participants

Start Date

Apr 16, 2014

Study Type

OBSERVATIONAL

Conditions

Chronic Myeloid Leukemia (CML)

Summary

Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study is building a real-world registry (a large database) to track patients with chronic myeloid leukemia (CML) — a type of blood cancer — over time, to better understand how the disease progresses and how patients respond to treatment in everyday clinical settings. **You may be eligible if...** - You have been diagnosed with chronic myeloid leukemia (CML) - You are willing and able to sign a consent form **You may NOT be eligible if...** - You have had a bone marrow transplant (allograft) for CML without receiving tyrosine kinase inhibitor (TKI) treatment - You refuse or are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(14)

CH Annecy Genevois

Annecy, France

University Hospital, Caen

Caen, France

CHU Clemront-Ferrand

Clermont-Ferrand, France

Centre Hospitalier Emile Roux

Le Puy-en-Velay, France

University Hospital, Limoges

Limoges, France

Institut Paoli-Calmettes

Marseille, France

Centre Hospital, Nancy

Nancy, France

Bicetre Hospital

Paris, France

Hopital Paul Brousse

Paris, France

Rennes University Hospital

Rennes, France

Centre Hospitalier de Rochefort

Rochefort, France

Centre Hospitalier Universitaire de Saint Etienne

Saint-Etienne, France

University Hospital, Toulouse

Toulouse, France

Versailles Hospital

Versailles, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05963061

Related Trials

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

NCT065145346 locations

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT055898969 locations

Quality of Life and Care Organization of Patients With Chronic Myeloid Leukemia in the Lombardy Hematology Network

NCT071655351 location

EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors

NCT0348186816 locations